These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7438121)

  • 1. A comparison of vindesine administration by bolus injection and by 24-hour infusion.
    Gilby ED
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():47-51. PubMed ID: 7438121
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous infusion vindesine in solid tumors.
    Bodey GP; Yap HY; Yap BS; Valdivieso M
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():39-45. PubMed ID: 7438120
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of vindesine in advanced neoplastic disease.
    Stambaugh JE
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity and pharmacology of bolus vindesine injection and prolonged vindesine infusion.
    Hande K; Gay J; Gober J; Greco FA
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():25-30. PubMed ID: 7438118
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of vindesine bolus and infusion.
    Jackson DV; Sethi VS; Long TR; Muss HB; Spurr CL
    Cancer Chemother Pharmacol; 1984; 13(2):114-9. PubMed ID: 6467494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans.
    Ohnuma T; Norton L; Andrejczuk A; Holland JF
    Cancer Res; 1985 Jan; 45(1):464-9. PubMed ID: 3965152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous vindesine infusion in advanced head and neck cancer.
    Popkin JD; Bromer RH; Vaughan CW; Byrne RE; Licciardello JT; Hoffer SM; Welch JM; Fofonoff SA; Strong MS; Hong WK
    Am J Clin Oncol; 1983 Jun; 6(3):301-4. PubMed ID: 6846248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion.
    Ohnuma T; Greenspan EM; Holland JF
    Cancer Treat Rep; 1980 Jan; 64(1):25-30. PubMed ID: 6929728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vindesine in oral cancers].
    Szpirglas H; Marneur M; Vaillant JM
    Presse Med; 1985 Feb; 14(7):405-7. PubMed ID: 3157128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and II studies of vindesine.
    Valdivieso M
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():31-7. PubMed ID: 7438119
    [No Abstract]   [Full Text] [Related]  

  • 12. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
    Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
    Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized study of continuous infusion vindesine versus vinblastine in adults with refractory metastatic sarcomas.
    Yap BS; Benjamin RS; Plager C; Burgess MA; Papadoupoulos N; Bodey GP
    Am J Clin Oncol; 1983 Apr; 6(2):235-8. PubMed ID: 6829497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
    Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
    Miller TP; Jones SE; Chester AB; Dorr RT
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
    [No Abstract]   [Full Text] [Related]  

  • 16. Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot study.
    Haas CD; Fabian CJ; Stephens RL; Kish J
    Invest New Drugs; 1983; 1(4):339-40. PubMed ID: 6678881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Localized epidermal necrolysis after intravenous injection of vinorelbine].
    Misery L; Perrot JL; Vergnon JM; Boucheron S; Emonot A; Claudy A
    Presse Med; 1992 Dec 19-26; 21(44):2153. PubMed ID: 1297136
    [No Abstract]   [Full Text] [Related]  

  • 18. A 125I-radiolabelled probe for vinblastine and vindesine radioimmunoassays: applications to measurements of vindesine plasma levels in man after intravenous injections and long-term infusions.
    Rahmani R; Barbet J; Cano JP
    Clin Chim Acta; 1983 Mar; 129(1):57-69. PubMed ID: 6851151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of vindesine: repeated treatments by intravenous bolus injections.
    Rahmani R; Martin M; Favre R; Cano JP; Barbet J
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1409-17. PubMed ID: 6542010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of vindesine infusion.
    Rahmani R; Kleisbauer JP; Cano JP; Martin M; Barbet J
    Cancer Treat Rep; 1985; 69(7-8):839-44. PubMed ID: 2410121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.